Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion
Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
The aim of this review is to investigate the effectiveness and safety of anti‐vascular endothelial growth factor (VEGF) agents for the treatment of macular oedema (MO) secondary to branch retinal vein occlusion (BRVO).